| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | linifanib | CTRPv2 | pan-cancer | AAC | 0.023 | 0.6 |
| mRNA | Salubrinal | GDSC1000 | pan-cancer | AAC | -0.035 | 0.6 |
| mRNA | KU-55933 | GDSC1000 | pan-cancer | AAC | -0.022 | 0.6 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | -0.026 | 0.6 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | 0.024 | 0.6 |
| mRNA | azacitidine | CTRPv2 | pan-cancer | AAC | 0.023 | 0.6 |
| mRNA | VER-155008 | CTRPv2 | pan-cancer | AAC | 0.021 | 0.6 |
| mRNA | BRD-K19103580 | CTRPv2 | pan-cancer | AAC | 0.022 | 0.6 |
| mRNA | SGX-523 | CTRPv2 | pan-cancer | AAC | -0.022 | 0.6 |
| mRNA | AGK-2 | CTRPv2 | pan-cancer | AAC | 0.022 | 0.6 |